NDC 59651-329-05 - Montelukast Sodium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 59651-329
- Requested NDC
- 59651-329-05
- Package NDCs from labels
- 59651-329-05, 59651-329-30
- Manufacturer
- Aurobindo Pharma Limited | APL HEALTHCARE LIMITED
- Effective date
- 2023-06-03
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Montelukast Sodium - Aurobindo Pharma Limited | APL HEALTHCARE LIMITED | Aurobindo Pharma Limited | APL HEALTHCARE LIMITED | 2023-06-03 | Human Prescription Drug Label |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 59651-329-05 | Montelukast Sodium | 1 in 1 PACKET | GRANULE | 1 | 8 | |
| 59651-329-30 | Montelukast Sodium | 30 in 1 CARTON | GRANULE | 30 | 8 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 59651-329-05 | EA - Each | 59651-329 | e8b349b0-c140-4415-b266-91a356d22ecf | 1 | 2020-08-06 |
| 59651-329-30 | EA - Each | 59651-329 | 2f798ca3-e322-4870-a1fe-0b94e5707559 | 1 | 2020-08-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Montelukast | MONTELUKAST | Coupler LLC | 583a9499-97f0-2ebf-e063-6394a90a35af | 2026-08-04 | Boxed warning, Warnings, Adverse reactions | U1O3J18SFL |
| Montelukast Sodium | MONTELUKAST SODIUM | Torrent Pharmaceuticals Limited | da038cf6-cfad-43a4-ab8e-d81d028d6087 | 2026-07-28 | Boxed warning, Warnings, Adverse reactions | 351246 U1O3J18SFL |
| montelukast sodium | MONTELUKAST SODIUM | Preferred Pharmaceuticals Inc. | 1eeb3123-9e93-4681-8096-800a7c7acf8a | 2026-07-28 | Boxed warning, Warnings, Adverse reactions | U1O3J18SFL |
| Montelukast | MONTELUKAST | Preferred Pharmaceuticals, Inc. | 94642db1-5c75-44c4-92b4-8385b486df82 | 2026-07-28 | Boxed warning, Warnings, Adverse reactions | U1O3J18SFL |
| Montelukast Sodium | MONTELUKAST SODIUM | Preferred Pharmaceuticals Inc. | 64a3b181-e8d8-4caf-9f1b-e0063d0bd94a | 2026-07-28 | Boxed warning, Warnings, Adverse reactions | U1O3J18SFL |
| Montelukast Sodium | MONTELUKAST SODIUM | Rising Pharma Holdings, Inc. | 49669ac0-0bb5-4576-bed5-9e85e0d76a44 | 2026-05-29 | Boxed warning, Warnings, Adverse reactions | U1O3J18SFL |
| Mannitol | MANNITOL | Hospira, Inc. | 8ad3145e-00e7-4412-b9a5-06f00f264f30 | 2026-04-21 | Warnings, Adverse reactions | 3OWL53L36A |
| Montelukast | MONTELUKAST | REMEDYREPACK INC. | ecaa9b4b-5941-4af5-930c-35e9f3b2b4ba | 2026-04-03 | Boxed warning, Warnings, Adverse reactions | U1O3J18SFL |
| Montelukast | MONTELUKAST | AvPAK | d7870c45-5a8b-8369-e053-2a95a90ae1f3 | 2026-01-08 | Boxed warning, Warnings, Adverse reactions | U1O3J18SFL |
| Montelukast Sodium | MONTELUKAST SODIUM | Redpharm Drug | 2fbdf1be-a37f-879b-e063-6394a90aa20d | 2025-12-30 | Boxed warning, Warnings, Adverse reactions | U1O3J18SFL |
| MONTELUKAST SODIUM | MONTELUKAST SODIUM | Chartwell RX, LLC | 5cb4298c-10b1-4d6f-95ad-4aad72daf249 | 2025-12-17 | Boxed warning, Warnings, Adverse reactions | U1O3J18SFL |
| Montelukast Sodium | MONTELUKAST SODIUM | AvKARE | ed2caffa-a75c-1c27-ae30-2d8280eaea7d | 2025-12-16 | Warnings, Adverse reactions | U1O3J18SFL |
| MONTELUKAST | MONTELUKAST SODIUM | A-S Medication Solutions | da9821f1-536a-416b-9594-210bde0cefaf | 2025-12-11 | Boxed warning, Warnings, Adverse reactions | U1O3J18SFL |
| QR PAIN | ANALGESIC | MARYHELENE ENTERPRISES INC | 8f8f53e3-fe31-e7b5-e053-2995a90a710d | 2025-11-14 | Warnings | 3OWL53L36A |
| QR PAIN | ANALGESIC | MARYHELENE ENTERPRISES INC | 9984a510-30be-4013-e053-2995a90a841e | 2025-11-14 | Warnings | 3OWL53L36A |
| Mannitol | MANNITOL | ProPharma Distribution | 430669d7-9ad1-9a04-e063-6394a90ababb | 2025-11-07 | Warnings, Adverse reactions | 3OWL53L36A |
| Sorbitol-Mannitol | SORBITOL AND MANNITOL | ICU Medical Inc. | 5b44e248-4b7b-4777-954a-921c7b309944 | 2025-10-30 | Warnings, Adverse reactions | 3OWL53L36A |
| Montelukast Sodium | MONTELUKAST SODIUM | AvPAK | 2f90a573-27fd-cc16-f3d1-8c4d630224a0 | 2025-10-29 | Warnings, Adverse reactions | U1O3J18SFL |
| Mannitol | MANNITOL | ICU Medical Inc. | ba7bf864-8a4d-4262-8fd1-00174fa2f9d1 | 2025-10-24 | Warnings, Adverse reactions | 3OWL53L36A |
| Montelukast Sodium | MONTELUKAST SODIUM | PD-Rx Pharmaceuticals, Inc. | c9ec1996-6a54-4622-b8a6-57dea49f6b35 | 2025-10-16 | Boxed warning, Warnings, Adverse reactions | U1O3J18SFL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.